news.cision.com

Metsä Fibre press release 24.9.2020Metsä Fibre, part of Metsä Group, and ANDRITZ signed a preliminary agreement on wood raw material reception and feed equipment for the Kemi bioproduct mill. The delivery includes two automated overhead cranes, as well as their installation and commissioning. This type of fully autonomous, AI-based equipment is a new solution for the reception, storage and process feeding of wood raw material, even on a global scale. It also enables the minimisation of the area needed at the mill for storing wood raw material. The domestic rate of the delivery is 45% and

Attana and ExpreS[2]ion Biotech have signed a Development & Supply Agreement

Attana AB (“Attana”) hereby announces that it has signed a heads of terms agreement regarding the development and supply of novel proteins from ExpreS[2]ion Biotechnologies ApS (“ExpreS[2]ion"). The first target protein will be the ExpreS[2]ion-produced SARS-CoV-2 spike and receptor-binding-domain (RBD) antigen used in ExpreS[2]ion’s COVID-19 vaccine program. Attana will now be able to offer customers utilising its AVA diagnostic platform, this and other novel ExpreS[2]ion proteins. The parties are not disclosing the commercial terms of the agreement.In early June, ExpreS[2]ion announced (

Heimstaden Bostad AB forms new joint ventures with Magnolia Bostad and Derome

Heimstaden Bostad AB has signed an agreement with Magnolia Bostad AB to jointly acquire land from Derome AB in Kungsbacka, Sweden. Together, the two companies will develop and construct approximately 1,600 apartments with a total area of 100,000 sq.m., subject to regulatory approval. The project value upon completion is estimated to SEK 3.0 billion. With this project, Heimstaden Bostad AB will significantly strengthen its presence in the Gothenburg region. In conjunction with the aforementioned transaction, Heimstaden Bostad AB, Magnolia Bostad AB and Derome AB have entered into a joint

Magnolia Bostad forms new joint ventures with Heimstaden Bostad and Derome

Magnolia Bostad has signed agreements with Heimstaden Bostad regarding the joint development of land for the construction of apartment blocks next to Hede station in Kungsbacka. The project consists of around 1,600 apartments with a total area of about 100,000 m[2] GFA. The seller is Derome, which will continue to have a large share of land in the total development area after the transaction. In connection with Derome selling the land next to Hede station in Kungsbacka, Heimstaden Bostad, Magnolia Bostad and Derome have signed a agreement regarding a jointly-owned company where the

Heimstaden Bostad AB forms new joint ventures with Magnolia Bostad and Derome

Thu, Sep 24, 2020 08:57 CET

Heimstaden AB's subsidiary, Heimstaden Bostad AB has signed an agreement with Magnolia Bostad AB to jointly acquire land from Derome AB in Kungsbacka, Sweden. Together, the two companies will develop and construct approximately 1,600 apartments with a total area of 100,000 sq.m., subject to regulatory approval. The project value upon completion is estimated to SEK 3.0 billion. With this project, Heimstaden Bostad AB will significantly strengthen its presence in the Gothenburg region. In conjunction with the aforementioned transaction, Heimstaden Bostad AB, Magnolia Bostad AB and Derome

FREYR adds VP of Operations and product engineer to advance Norway’s first LiB battery production facility

FREYR has appointed Kenneth Yan as VP of Operations and Eirik Børsheim as Product Manager to advance Norway’s first LiB battery production facility. Both will join the company later this year to accelerate FREYRs development of the fast-track and giga-scale facilities in Mo i Rana, Norway.“Our business model and strategy combined with our expanding team of industry professionals and the comparative benefits of Norway, attract some of the best talents in the battery industry”, says CEO Tom Einar Jensen The new VP of Operations, Kenneth Yan, has for the past two years been CEO of Cham

BioStock: Ultimovacs on track to develop universal cancer vaccine

Thu, Sep 24, 2020 08:46 CET

Cancer’s heavy burden on society has created a strong demand for new innovative therapeutic solutions. Over the last decade, immunotherapy has emerged as one of the most promising fields within oncology, and several biotech and pharma companies are exploiting this promise by developing immunotherapy-based drugs. Norwegian Ultimovacs is one of them. Their immunotherapy technology may work as a vaccine for treating all forms of cancer. BioStock takes an in-depth look at the company.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-on-track-to-develop-universal-

Exercise of options

Thu, Sep 24, 2020 08:44 CET

Issue of equityCompany announcement, 24 September 2020 at 9.15 (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received notifications from option holders to exercise D options over 15,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 1.00) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option Plan are available on the Company’s website at https://www.faron.com/sites/default/files/Option%20Plan%

Half-year report

Thu, Sep 24, 2020 08:41 CET

· Development of novel cancer immunotherapy Clevegen[®] (bexmarilimab) continues in Phase I/II MATINS trial across 10 tumour types · IV interferon beta-1a, Traumakine[®], being investigated as potential COVID-19 treatment in two ongoing global trials with preparations for US trial underway · Successful €14 million placing in April strengthens Company’s balance sheet · Additional grants of €3.3 million and €4.6 million loans awarded to drive R&D and CMC programmesHalf-year report, 24 September 2020 at 9.00 AM (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First

Atlas Copco AB’s Nomination Committee for the Annual General Meeting 2021

Stockholm, Sweden, September 24, 2020: The following representatives of Atlas Copco AB’s shareholders, together with the Chair of the Board, Hans Stråberg, will form the nomination committee for the Annual General Meeting 2021.Representanter:Petra Hedengran, Investor AB (ordförande)Jan Andersson, Swedbank Robur fonderMikael Wiberg, AlectaJaviera Ragnartz, SEB Investment Management AB The Annual General Meeting of Atlas Copco AB will be held on April 27, 2021, at 16.00.Shareholders who wish to submit proposals to the nomination committee can do so by e-mailing the secretary of

Storytel to launch in Belgium in the fourth quarter of 2020

Storytel, one of the world’s leading audiobook and e-book streaming services, will be launching its service in Belgium during the fourth quarter of 2020. The Belgian service will be operated from the office of Storytel Netherlands.Belgium is a digitally mature market with an urban population, a strong literary storytelling tradition, and with high confidence in digital products, payment solutions, and streaming services. Belgium is also geographically adjacent to the Netherlands, one of Storytel’s strongest non-Nordic markets. Belgium is a densely populated country with 11.5 million

SRV Group Plc’s financial information in 2021

SRV GROUP PLC STOCK EXCHANGE RELEASE 24 SEPTEMBER 2020 9.30 EET SRV Group Plc’s financial information in 2021 SRV Group Plc will publish the following financial information in 2021: · Financial Statement Release 2020 will be published on Thursday, 4 February 2021 at 8.30 am. · Annual Report 2020 (including the Financial Statements and the Report of the Board of Directors) will be published on Friday, 5 March 2021. · Interim Report for January-March 2021 will be published on Thursday, 29 April 2021 at 8.30 am. · Half-year Report for January-June 2021 will be

Revolutionary Volvo Penta-powered electric fire trucks are on their way to customers

Three pioneering fire trucks featuring Volvo Penta electric drivelines are on their way to fire departments in Berlin, Amsterdam and Dubai to begin real-world customer testing.Volvo Penta has developed an electric driveline for leading fire service vehicle manufacturer Rosenbauer’s pioneering fire truck, named “Revolutionary Technology” (RT). The truck – which features groundbreaking drive technology, vehicle architecture, operability and connectivity – was

HKScan Corporation’s financial reporting in 2021

HKScan Corporation, Stock Exchange Release, 24 September 2020, at 9:00 Finnish timeHKScan Corporation’s financial reporting in 2021 HKScan Corporation will publish its Financial Statement release on Thursday 4 February 2021, at approximately 8:30 a.m. EET. The Annual Report for 2020 will be published online in March in week 11/2021 at the latest. The Annual Report will also include the Corporate Responsibility Report. The Annual General Meeting is planned to be held in Turku on Thursday, 8 April 2021. The invitation to HKScan’s Annual General Meeting will be published later as a

ExpreS2ion and Attana have signed a Development and Supply Agreement

Hørsholm, Denmark, September 24, 2020 – ExpreS2ion Biotech Holding AB hereby announces that its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") and the biotech tools company Attana AB (“Attana”) have today signed a heads of terms agreement regarding the development and supply of novel ExpreS2ion proteins to Attana. The first target protein will be the ExpreS2ion-produced SARS-CoV-2 spike and receptor-binding-domain (RBD) antigen used in ExpreS2ion’s COVID-19 vaccine program. Attana will now be able to offer customers utilising its AVA diagnostic platform this and other novel

Mycronic appoints Nomination Committee

The Nomination Committee for Mycronic’s 2021 Annual General Meeting has been appointed in accordance with the instructions for the Nomination Committee as decided by the 2020 Annual General Meeting. The Nomination Committee comprises: · Henrik Blomquist, Bure Equity · Per Trygg, SEB Funds · Thomas Ehlin, The Fourth Swedish National Pension Fund · Patrik Tigerschiöld, Chairman The Nomination Committee represents 47.6 percent of votes and shares as of 31 August, 2020. Shareholders who wish to submit proposals to the Nomination Committee are welcome to contact the

SAS flying to China again

From 29 September, it will once again be possible to fly direct from Scandinavia to China with SAS. There have been no direct flights since 31 January, but SAS has now obtained approval from the Chinese authorities and is reopening the route from Copenhagen to Shanghai with a weekly frequency.The reopening of the route is vital for trade. With the reopening of the route, SAS is aiming to meet demand for business travel and air freight services between Scandinavia and China. At the end of October, SAS is also planning to resume flights to Beijing provided that SAS obtains the necessary

Stora Enso starts the production of new-generation formed fiber products free from plastic and PFAS